CONCIERGE CLINICAL TRIALS

Live / Applied — Non-final action mailed (as of 03 Dec 2025)

What this means for you

Not registered yet, but its 17 Oct 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.

Record

Serial number
98807788
Mark type
Design + words
Filed
17 Oct 2024
Attorney of record
John P. Rynkiewicz

Goods and services

  • Class 035 — Advertising and business services: Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of pharmaceutical and biotechnology companies to assist them with clinical research, clinical trials, recruiting patients for trials and proceeding through the drug protocols, collection of data and reporting same to drug companies; Computerized database management, namely, editing, evaluating and processing data for third parties; Recruitment advertisement services, namely, recruiting patients for participation in clinical trials for the testing of drugs
  • Class 042 — Scientific and technological services: Scientific investigations for medical, drug and chemical compounds efficacy purposes; Providing medical and scientific research information in the field of drugs, compounds and clinical trials; Providing medical and scientific research, namely, conducting investigations and clinical trials for drug companies; Consulting services in the field of clinical trial investigations and research for pre-approved and post-approved compounds or drugs; Consulting services in the field of pharmaceutical research and development; Technical research in the field of pharmaceutical studies; Scientific research in the nature of conducting investigations and clinical trials for drug companies; Pharmaceutical product, investigations and clinical trials evaluation; Pharmaceutical research services; Pharmaceutical research and development; scientific research for others in the field of clinical studies, namely, managing clinical trials and studies of pharmaceutical and biotechnology products to the order and specification of drug companies

Owner

Prosecution history

  • 03 Mar 2026 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
  • 03 Mar 2026 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
  • 03 Dec 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
  • 03 Dec 2025 — NON-FINAL ACTION E-MAILED
  • 03 Dec 2025 — NON-FINAL ACTION WRITTEN
  • 30 Oct 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
  • 30 Oct 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
  • 30 Oct 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
  • 30 Jul 2025 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
  • 30 Jul 2025 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
  • 30 Apr 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
  • 30 Apr 2025 — NON-FINAL ACTION E-MAILED
  • 30 Apr 2025 — NON-FINAL ACTION WRITTEN
  • 21 Apr 2025 — ASSIGNED TO EXAMINER
  • 19 Apr 2025 — NOTICE OF DESIGN SEARCH CODE E-MAILED

View this trademark record on Marksy